IP Library Granted Patent US 7,560,237
Granted Patent B2
US 7,560,237 · App. 09/096,593 · Granted Jul 14, 2009

Electronics method for the detection of analytes

Assignee: Osmetech Technology Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,560,237
App. No.
09/096,593
Granted
Jul 14, 2009
Kind
B2
Abstract

The present invention is directed to the detection of target analytes using electronic techniques, particularly AC techniques.

Claims (39)

1. An apparatus for the detection of a protein target analyte in a test sample, comprising:

a) a test chamber comprising an array of first measuring electrodes each comprising:

a passivation agent monolayer comprising at least a covalently attached first passivation species and a covalently attached second passivation species comprising a protein binding ligand;

wherein said protein binding ligand is covalently attached to said electrode via a spacer;

wherein said test chamber further comprises at least one second measuring electrode; and

b) a voltage source electrically connected to said test chamber.

2. An apparatus according to claim 1 wherein said spacer is a conductive oligomer having the formula:

wherein

Y is an aromatic group;

n is an integer from 1 to 50;

g is either 1 or zero;

e is an integer from zero to 10; and

m is zero or 1;

wherein when g is 1, B-D is a conjugated bond; and

wherein when g is zero, e is 1 and D is preferably carbonyl, or a heteroatom moiety, wherein the

heteroatom is selected from oxygen, sulfur, nitrogen, silicon or phosphorus.

3. An apparatus according to claim 1 wherein said spacer is a conductive oligomer having the formula:

wherein

n is an integer from 1 to 50;

m is 0 or 1;

C is carbon;

J is carbonyl or a heteroatom moiety, wherein the heteroatom is selected from the group consisting of oxygen, nitrogen, silicon, phosphorus, sulfur; and

G is a bond selected from alkane, alkene or acetylene, wherein if m=0, at least one G is not alkane.

4. An apparatus for the detection of a non-nucleic acid target analyte in a test sample comprising:

a) a test chamber comprising an array of electrodes each comprising:

a passivation agent monolayer comprising at least a covalently attached first passivation species and a covalently attached second passivation species comprising a protein binding ligand;

wherein said protein binding ligand is covalently attached to said electrode via a spacer;

wherein said test chamber further comprises at least one second measuring electrode; and

b) a voltage source electrically connected to said test chamber; and

c) an electronic detector.

5. An apparatus according to claim 1 or 4 wherein said passivation agent monolayer comprises insulators.

6. An apparatus according to claim 1 or 4 wherein said passivation agent monolayer comprises conductive oligomers.

7. An apparatus according to claim 1 or 4 wherein said passivation agent monolayer comprises insulators and conductive oligomers.

8. An apparatus according to claim 1 or 4 wherein said binding ligand is a protein.

9. An apparatus according to claim 1 or 4 further comprising a processor coupled to said electrodes and configured to receive an output signal.

10. An apparatus according to claim 1 or 4 wherein said protein binding ligand is a peptide.

11. An apparatus according to claim 1 or 4 wherein said electrode comprises a member selected from the group consisting of gold, platinum, and graphite.

12. An apparatus according to claim 1 or 4 wherein said passivation agent comprises polyalkyl chains.

13. An apparatus according to claim 1 or 4 wherein said passivation agent comprises nonconductive oligomers.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2013
From: O'CONNOR, STEPHEN D.; KAYYEM, JON FAIZ; MEADE, THOMAS J.
To: CLINICAL MICRO SENSORS, INC., DBA OSMETECH TECHNOLOGY INC.
Reel/Frame 031220/0385 →
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2012
From: SQUARE 1 BANK
To: OSMETECH TECHNOLOGY, INC.
Reel/Frame 029097/0148 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INVENTORS PREVIOUSLY RECORDED ON REEL 009555 FRAME 0326. ASSIGNOR(S) HEREBY CONFIRMS THE ADDITION OF JON FAIZ KAYYEM AS AN INVENTOR. Recorded May 10, 2010
From: O'CONNOR, STEPHEN D.; KAYYEM, JON FAIZ; MEADE, THOMAS J.
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 024358/0298 →
SECURITY INTEREST Recorded Apr 1, 2010
From: OSMETECH TECHNOLOGY INC.
To: SQUARE 1 BANK
Reel/Frame 024312/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2009
From: CLINICAL MICRO SENSORS, INC., DBA OSMETECH MOLECULAR DIAGNOSTICS
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 022378/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2008
From: CLINICAL MICRO SENSORS INC. (DBA OSMETECH MOLECULAR DIAGNOSTICS)
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 021924/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 1998
From: O'CONNOR, STEPHEN D.; MEADE, THOMAS J.
To: CLINICAL MICRO SENSORS
Reel/Frame 009555/0326 →
Continuity (2)
Provisional Application 6004948900 · Jun 12, 1997
Related Publication 20020009810A1 · Jan 24, 2002